Pulmonary complications of sickle cell disease
Gregory J Kato Andrew Miller Mark T. Gladwin
Andrew Miller
Miller Andrew
ORCID: 0000-0001-8474-5090
Early immunologic responses to trauma in the emergency department patients with major injuries 10.1016/j.resuscitation.2008.09.012
Disasters and women's health: Reflections from the 2010 earthquake in Haiti 10.1017/S1049023X12001677
Pulmonary complications of sickle cell disease 10.1164/rccm.201111-2082CI
Predictive models for tuberculous pleural effusions in a high tuberculosis prevalence region 10.1007/s00408-011-9342-z
Use of Probiotics for Treatment of Chemotherapy-induced Diarrhea: Is It a Myth? 10.1177/0148607109336596
Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: A systematic review 10.1097/CCM.0b013e3182a645e5
Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers 10.1016/j.jaad.2010.06.014
Brain death and islam: The interface of religion, culture, history, law, and modern medicine 10.1378/chest.14-0130
A novel presentation of a rare chromosome 21q22.2 deletion 10.1097/MCD.0b013e3283157dc6
Influenza A 2009 (H1N1) virus in admitted and critically III patients 10.1177/0885066610393626
Three episodes of acquired pure red cell aplasia restricted to pregnancy 10.1515/JPM.2008.041
Novel influenza A(H1N1) virus among gravid admissions 10.1001/archinternmed.2010.126
Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury 10.1097/BCR.0b013e318198a268
Malignant mesothelioma and central nervous system metastases: Report of two cases, pooled analysis, and systematic review 10.1513/AnnalsATS.201404-165BC
Opinions on the Legitimacy of Brain Death Among Sunni and Shi’a Scholars 10.1007/s10943-015-0157-8
Secondary Syphilis 10.1016/j.jemermed.2007.02.048
Proptosis and painless loss of vision: A rare case of CD20+ orbital T-cell lymphoma 10.3129/i09-272
Chronic diseases and natural hazards: Impact of disasters on diabetic, renal, and cardiac patients 10.1017/S1049023X00005835
Fever of unknown origin and isolated noncaseating granuloma of the marrow: Could this be sarcoidosis? 10.2500/aap.2007.28.2982
Disasters, women's health, and conservative society: Working in pakistan with the turkish red crescent following the south asian earthquake 10.1017/S1049023X00004842
Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? 10.1111/acem.12011
Jundi-Shapur, bimaristans, and the rise of academic medical centres 10.1258/jrsm.99.12.615
A systematic review and pooled analysis of CPR-associated cardiovascular and thoracic injuries 10.1016/j.resuscitation.2014.01.028
Chronic rhinosinusitis and psoriasis: Do mutually exclusive systemic Th1 and Th2 disease patterns exist? 10.1080/00016480601002054
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression 10.1126/scitranslmed.3006941
Immune enteral nutrition can improve outcomes in medical-surgical patients with ARDS: A prospective randomized controlled trial. 10.4172/jndt.1000109
Obesity, Anemia, and Cardiovascular Risk in Patients with Chronic Kidney Disease: Overview and Pathophysiologic Insights. 10.1007/s12170-009-0018-7
Cardiac rehabilitation using the Family-Centered Empowerment Model versus home-based cardiac rehabilitation in patients with myocardial infarction: a randomised controlled trial 10.1136/openhrt-2015-000349
Experimental assessment and future applications of the shikani tracheostomy speaking valve 10.1044/2015_AJSLP-14-0115
Effect of the Cardio First Angel™ device on CPR indices: A randomized controlled clinical trial 10.1186/s13054-016-1296-3
Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis 10.1186/s13613-016-0138-4
Epidemiology of Smoke Inhalation-associated Acute Lung Injury: Predictors of Mortality from 68 hospitals in the United States. 10.1016/j.chest.2016.06.008
Impact of the Affordable Care Act Medicaid expansion on emergency department high utilizers with ambulatory care sensitive conditions: A cross-sectional study 10.1016/j.ajem.2017.01.014
High-Frequency Ventilation Modalities as Salvage Therapy for Smoke Inhalation-Associated Acute Lung Injury 10.1177/0885066617714770
Effects of Stress on Critical Care Nurses: A National Cross-Sectional Survey. 10.1177/0885066617696853
Post-ICU Psychological Morbidity in Patients with ARDS and Delirium 10.1016/j.jcrc.2017.08.034
A Comprehensive Framework for International Medical Programs: A Consensus Statement from the American College of Academic International Medicine. 10.4103/IJAM.IJAM_88_17
The American College of Academic International Medicine 2017 Consensus Statement on International Medical Programs: Establishing a System of Objective Valuation and Quantitative Metrics to Facilitate the Recognition and Incorporation of Academic International Medical Efforts into Existing Promotion and Tenure Paradigms. 10.4103/IJAM.IJAM_84_17
A Comprehensive Framework for International Medical Programs: A Consensus Statement from the American College of Academic International Medicine. 10.4103/IJCIIS.IJCIIS_65_17
The american college of academic international medicine 2017 consensus statement on international medical programs: Establishing a system of objective valuation and quantitative metrics to facilitate the recognition and incorporation of academic international medical efforts into existing promotion and tenure paradigms 10.4103/IJCIIS.IJCIIS_64_17
Spiritual Health and Outcomes in Muslim ICU Patients: A National Structural Equation Modeling Study 10.1007/s10943-017-0543-5
10 Minute ENT Clinical Consult 10.1016/j.annemergmed.2009.12.003
Coadministration of Probiotics With Prescribed Antibiotics for Preventing Clostridium difficile Diarrhea 10.1111/acem.13557
Antivirals With Corticosteroids for the Treatment of Acute Bell's Palsy 10.1111/acem.13563
Single Maintenance and Reliever Therapy ( SMART ) Regimen for Management of Persistent Asthma 10.1111/acem.13659
Neuroleptanalgesia for acute abdominal pain: a systematic review 10.2147/JPR.S187798
Impact of Religiosity on Delirium Severity Among Critically Ill Shi’a Muslims: A Prospective Multi-Center Observational Study 10.1007/s10943-019-00895-7
Impact of United States political sanctions on international collaborations and research in Iran 10.1136/bmjgh-2019-001692
Intravenous Magnesium Sulfate to Treat Acute Headaches in the Emergency Department: A Systematic Review 10.1111/head.13648
Real-time compression feedback for patients with in-hospital cardiac arrest: a multi-center randomized controlled clinical trial 10.1186/s40560-019-0357-5
United States federal government regulation of international research collaborations: What every physician-scientist should know 10.4103/ijciis.ijciis_63_18
A rapid shallow breathing index threshold of 85 best predicts extubation success in chronic obstructive pulmonary disease patients with hypercapnic respiratory failure 10.21037/jtd.2019.03.103
Infection prevention for open fractures: Is antibiotic monotherapy equivalent to multitherapy? 10.4103/ijciis.ijciis_79_19
Opinions on the Legitimacy of Death Declaration by Neurological Criteria from the Perspective of 3 Abrahamic Faiths 10.5222/mmj.2019.48379
The "T" in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients. 10.1097/TA.0b013e31815b839e
Preparing for and responding to mass casualties and disasters. 10.1001/virtualmentor.2010.12.9.fred1-1009
Mandated influenza vaccines and health care workers' autonomy. 10.1001/virtualmentor.2010.12.9.ccas2-1009
A comparison of commercially available compression feedback devices in novice and experienced healthcare practitioners: A prospective randomized simulation study 10.1002/mds3.10020
Comparison of non-invasive to invasive oxygenation ratios for diagnosing acute respiratory distress syndrome following coronary artery bypass graft surgery: a prospective derivation-validation cohort study. 10.1186/s13019-018-0804-8
What's new in critical illness and injury science? Utility of central venous oxygen saturation to risk stratify septic patients 10.4103/ijciis.ijciis_100_19
What's new in Academic International Medicine? Highlighting the need for establishing a national accreditation system for International Medical Programs 10.4103/ijam.ijam_68_19
The Fourth Annual Academic International Medicine Congress (AIM 2019) in Philadelphia, Pennsylvania, July 26–28, 2019: Advancing Global Leadership to Promote Health Equity 10.4103/ijam.ijam_61_19
Natural versus artificial light exposure on delirium incidence in ARDS patients 10.1186/s13613-020-0630-8
Magnesium’s Analgesic Effects are Independent of Serum Concentration 10.1111/head.13763
Immune Enteral Nutrition Can Improve Outcomes in Medical-Surgical Patients with ARDS: A Prospective Randomized Controlled Trial 10.4172/2161-0509.1000109
Paracetamol for low back pain 10.1002/14651858.CD012230
Ethical Issues Confronting Muslim Patients in Perioperative and Critical Care Environments 10.1016/j.anclin.2020.01.002
Pregnancy Outcomes of Wives of Chemical and Non-Chemical Weapons Exposed Veterans in Ahvaz, Iran: A Retrospective Cohort Study 10.1017/S1049023X2000076X
The Shikani HME: A New Tracheostomy Heat and Moisture Exchanger 10.1044/2020_JSLHR-19-00107
Clarification on Islamic Jurisprudence and Transplantation. 10.1097/txd.0000000000001022
The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper 10.4103/JGID.JGID_86_20
Squeale of Corticosteroids (CS) Therapy in Intensive Care Unit Patients 10.1164/AJRCCM-CONFERENCE.2010.181.1_MEETINGABSTRACTS.A6133
Clinical & Economic Impacts Of Corticosteroids Therapy In The Intensive Care Unit Patients 10.1164/AJRCCM-CONFERENCE.2011.183.1_MEETINGABSTRACTS.A1676
Pediatric Patients With 2009 H1N1 Did Not Differ Significantly From A 2005-2008 Seasonal Cohort In A New York City Teaching Hospital 10.1164/AJRCCM-CONFERENCE.2011.183.1_MEETINGABSTRACTS.A4151
Real-time audiovisual feedback during CPR: A clarification, meta-analysis update, and caution for interpretation 10.1016/j.resuscitation.2020.09.043
COVID-19 blind spots: A consensus statement on the importance of competent political leadership and the need for public health cognizance 10.4103/jgid.jgid_397_20
Real-time audio-visual feedback with handheld nonautomated external defibrillator devices during cardiopulmonary resuscitation for in-hospital cardiac arrest: A meta-analysis 10.4103/ijciis.ijciis_155_20
Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research 10.1097/CCE.0000000000000374
Growth through adversity: The impact of COVID-19 pandemic on the american college of academic international medicine 10.4103/IJAM.IJAM_162_20
What's new in Academic International Medicine? International health security agenda - Expanded and re-defined 10.4103/IJAM.IJAM_113_20
A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study 10.1186/s12890-021-01527-1
Gregory Kato
Kato Gregory / Gregory J. Kato / Gregory Kato, Greg Kato, GJ Kato, G Kato
ORCID: 0000-0003-4465-3217
Email: gregorykatomd@gmail.com
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin 10.1016/j.hoc.2013.11.001
No NO means yes to sickle red cell adhesion 10.1182/blood-2014-02-551218
An official american thoracic society clinical practice guideline: Diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease 10.1164/rccm.201401-0065ST
A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia 10.1002/ajh.23613
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors 10.1038/mt.2013.201
Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia 10.1097/MPH.0000000000000011
Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia 10.1002/ajh.23571
Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease 10.1002/ajh.23699
A Retrospective Review of Acupuncture Use for the Treatment of Pain in Sickle Cell Disease Patients 10.1097/AJP.0000000000000036
Mechanisms of hemolysis-associated platelet activation 10.1111/jth.12422
Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study 10.1371/journal.pone.0079923
Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells 10.1002/cyto.b.21088
Liver stiffness increases acutely during sickle cell vaso-occlusive crisis 10.1002/ajh.23532
Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease 10.3324/haematol.2013.092635
Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels 10.1016/j.amjcard.2013.06.035
A fluorescence method to detect and quantitate sterol esterification by lecithin:Cholesterol acyltransferase 10.1016/j.ab.2013.06.018
Lactate dehydrogenase and hemolysis in sickle cell disease. 10.1182/blood-2013-05-505016
Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis 10.1161/ATVBAHA.112.301068
Leg ulcers in sickle cell disease: Current patterns and practices 10.3109/03630269.2013.789968
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease 10.1111/ejh.12118
Reconstruction of thermographic signals to map perforator vessels in humans (vol 9, pg 123, 2012) 10.1080/17686733.2013.802421
Hemodynamic predictors of mortality in adults with sickle cell disease 10.1164/rccm.201207-1222OC
Expression of Regulatory Platelet MicroRNAs in Patients with Sickle Cell Disease 10.1371/journal.pone.0060932
Genetic determinants of haemolysis in sickle cell anaemia 10.1111/bjh.12245
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe 10.3324/haematol.2012.068965
Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin 10.3324/haematol.2012.066530
Characterizing non-linear dependencies among pairs of clinical variables and imaging data 10.1109/EMBC.2012.6346521
Reconstruction of thermographic signals to map perforator vessels in humans 10.1080/17686733.2012.737157
Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia" 10.5581/1516-8484.20120099
Understanding the erythrocyte storage lesion 10.1097/ALN.0b013e318272d8ac
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease 10.1016/j.mvr.2012.06.011
Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia 10.3324/haematol.2011.054957
Anemia, age, desaturation, and impaired neurocognition in sickle cell anemia 10.1002/pbc.24276
Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function 10.1038/oby.2012.56
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans 10.1182/blood-2012-06-432849
Non-invasive indicators of pulmonary hypertension from pulmonary veins quantification in sickle cell disease 10.1109/ISBI.2012.6235679
A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease 10.1164/rccm.201201-0057OC
A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease 10.1186/1755-8794-5-28
Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease 10.1182/blood-2011-11-392654
TRV: A physiological biomarker in sickle cell disease 10.1002/pbc.23399
Computer-assisted diagnostic tool to quantify the pulmonary veins in sickle cell associated pulmonary hypertension 10.1117/12.910966
Mortality in adults with sickle cell disease and pulmonary hypertension 10.1001/jama.2012.358
Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates 10.1002/ajh.22274
Framing the research agenda for sickle cell trait: Building on the current understanding of clinical events and their potential implications 10.1002/ajh.22271
High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women 10.1016/j.amjcard.2011.10.008
Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHLR200W mutation (Chuvash polycythemia) 10.3324/haematol.2011.051839
Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia 10.1016/j.jpeds.2011.07.018
Priapism in Sickle-Cell Disease: A Hematologist's Perspective 10.1111/j.1743-6109.2011.02287.x
Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia 10.1111/j.1365-2141.2011.08757.x
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom 10.1161/CIRCULATIONAHA.111.032920
Predictors of osteoclast activity in patients with sickle cell disease 10.3324/haematol.2011.042499
Laboratory and echocardiography markers in sickle cell patients with leg ulcers 10.1002/ajh.22065
NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease 10.1111/j.1365-2141.2011.08777.x
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity 10.1182/blood-2010-09-306167
Ancestry of African Americans with sickle cell disease 10.1016/j.bcmd.2011.04.002
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: A randomized controlled trial 10.1001/jama.2011.235
Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia 10.3324/haematol.2010.030767
The proteome of sickle cell disease: Insights from exploratory proteomic profiling 10.1586/epr.10.88
Increased pulmonary pressures and myocardial wall stress in children with severe malaria 10.1086/655225
Apolipoprotein A-I and serum amyloid a plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease 10.3324/haematol.2009.018044
Pulmonary hypertension and NO in sickle cell 10.1182/blood-2010-04-282095
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension 10.1182/blood-2009-09-244830
Diastolic dysfunction in sickle cell 10.1182/blood-2010-04-279919
Association of G6PD202A,376G with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia 10.1111/j.1365-2141.2010.08215.x
Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia 10.1089/ars.2009.2978
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa: Research paper 10.1111/j.1365-2141.2010.08195.x
Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension 10.1111/j.1365-2141.2010.08109.x
Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension 10.1118/1.3355892
Pleiotropic effects of intravascular haemolysis on vascular homeostasis 10.1111/j.1365-2141.2009.08004.x
Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes 10.3109/03630260903546999
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease 10.1111/j.1365-2141.2009.07906.x
Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease 10.1371/journal.pone.0007956
Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease 10.1182/blood-2009-04-218040
Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients 10.1111/j.1365-2141.2009.07854.x
Prospective Echocardiography Assessment of Pulmonary Hypertension and Its Potential Etiologies in Children With Sickle Cell Disease 10.1016/j.amjcard.2009.04.034
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions 10.1002/ajh.21475
Haptoglobin halts hemoglobin's havoc 10.1172/JCI40258
Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea 10.1002/ajh.21446
Near-infrared spectra absorbance of blood from sickle cell patients and normal individuals 10.1179/102453309X385133
Endogenous nitric oxide synthase inhibitors in sickle cell disease: Abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death 10.1111/j.1365-2141.2009.07658.x
Hematologic, biochemical, and cardiopulmonary effects of l-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy 10.1111/j.1600-0609.2009.01210.x
The authors and a colleague reply 10.1056/NEJMc082638
Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: Association with hemolysis and hemoglobin oxygen desaturation 10.3324/haematol.13812
Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease 10.1182/blood-2008-03-142604
Strategic plan for pediatric respiratory diseases research: An NHLBI working group report 10.1513/pats.200810-116CB
Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy 10.1001/jama.2008.598
Nitric oxide and arginine dysregulation: A novel pathway to pulmonary hypertension in hemolytic disorders 10.2174/156652408786241447
Sodium nitrite promotes regional blood flow in patients with sickle cell disease: A phase I/II study 10.1111/j.1365-2141.2008.07259.x
Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria 10.1002/ajh.21162
Chronic hyper-hemolysis in sickle cell anemia: Association of vascular complications and mortality with less frequent vasoocclusive pain 10.1371/journal.pone.0002095
Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease 10.1002/pbc.21336
Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia 10.1111/j.1365-2141.2008.07045.x
Pulmonary hypertension in children and adolescents with sickle cell disease 10.1007/s00246-007-9018-x
Sickle cell disease and pulmonary hypertension in Africa: A global perspective and review of epidemiology, pathophysiology, and management 10.1002/ajh.21057
Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease 10.1002/ajh.21035
Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency 10.1002/ajh.21016
Severe pulmonary hypertension in an adolescent with sickle cell disease 10.1002/ajh.21039
Hemolysis-associated hypercoagulability in sickle cell disease: The plot (and blood) thickens! 10.3324/haematol.12318
A network model to predict the risk of death in sickle cell disease 10.1182/blood-2007-04-084921
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin 10.1182/blood-2006-12-061697
Pulmonary hypertension in sickle cell disease: Relevance to children 10.1080/08880010601185892
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease 10.1161/CIRCULATIONAHA.106.658641
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease 10.1016/j.jacc.2006.09.038
Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease 10.1111/j.1365-2141.2006.06417.x
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes 10.1016/j.blre.2006.07.001
A novel defense against hemolytic-oxidative stress 10.1182/blood-2006-07-037424
N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease 10.1001/jama.296.3.310
Cerebrovascular disease associated with sickle cell pulmonary hypertension 10.1002/ajh.20642
Sickle cell disease and nitric oxide: A paradigm shift? 10.1016/j.biocel.2006.01.010
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease 10.1182/blood-2005-06-2373
Hemolysis-associated pulmonary hypertension in thalassemia 10.1196/annals.1345.058
Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality 10.1111/j.1365-2141.2005.05701.x
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension 10.1111/j.1365-2141.2005.05625.x
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease 10.1001/jama.294.1.81
Tumor pseudosyncytiae 10.1056/NEJMicm980667
Identification and characterization of the novel centrosome-associated protein CCCAP 10.1016/S0378-1119(02)01141-1
Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells 10.1182/blood.V99.9.3390
Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy 10.1017/S0012162299001541
Human genetic diseases of proteolysis 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K
The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors 10.1016/S0378-1119(97)00444-7
Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation 10.1097/00043426-199709000-00010
E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein 10.1093/nar/24.14.2813
Low-dose methotrexate therapy for hepatoblastoma 10.1007/BF00685519
Proteases and Human Disorders 10.1038/npg.els.0005165
Defective nitric oxide metabolism in sickle cell disease 10.1002/pbc.25297
Sickle Cell Disease-Associated Pulmonary Hypertension: The Effect of Anemia and High Cardiac Output 10.5275/ijcr.2011.07.08
Management of Patients With Sickle Cell Disease 10.1001/jama.2014.15898
New insights into sickle cell disease 10.1097/moh.0000000000000241
Biophysical markers of Sickle Cell Disease at Individual Cell Level 10.1364/cancer.2016.jtu3a.44
Inflammation and Sickle Cell Anemia 10.1007/978-3-319-06713-1_8
DNA binding by the Myc oncoproteins 10.1007/978-1-4615-3088-6_16
Iron deficiency decreases hemolysis in sickle cell anemia 10.1590/s1516-84842009005000009
Sickle Cell Imaging Flow Cytometry Assay (SIFCA) 10.1007/978-1-4939-3302-0_20
Mechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia 10.1017/cbo9780511596582.016
Iron restriction in sickle cell anemia: Time for controlled clinical studies 10.1002/ajh.24193
Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia" 10.5581/1516-8484.1516-8484.20120099
Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide 10.1111/bjh.13203
Sleep disturbance, depression and pain in adults with sickle cell disease 10.1186/1471-244x-14-207
Rapid vs. delayed infrared responses after ischemia reveal recruitment of different vascular beds 10.1080/17686733.2015.1046677
Mo1001 Nodular Regenerative Hyperplasia: Many Ways to Get There 10.1016/s0016-5085(14)63570-8
The Role of Free Radicals in Hemolysis Associated Platelet Activation 10.1016/j.freeradbiomed.2012.10.444
Circulating endothelial progenitor cells in adults with sickle cell disease 10.4103/2045-8932.114784
Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease 10.1086/675997
Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis 10.1073/pnas.1424111112
Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy 10.1111/j.1469-8749.1999.tb00538.x
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease 10.1371/journal.pone.0114309
Reply: Practice Guideline for Pulmonary Hypertension in Sickle Cell: Direct Evidence Needed before Universal Adoption 10.1164/rccm.201404-0733le
RV dysfunction by MRI is associated with elevated transpulmonary gradient and poor prognosis in patients with sickle cell associated pulmonary hypertension 10.1186/1532-429x-15-s1-o43
Critical Reviews: How we treat sickle cell patients with leg ulcers 10.1002/ajh.24134
Gout and sickle cell disease: not all pain is sickle cell pain 10.1111/bjh.13433
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression 10.1172/jci77393
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression 10.1172/jci74604
Strategic plan for pediatric respiratory diseases research: An NHLBI working group report 10.1002/ppul.20973
Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial 10.1016/s2352-3026(14)00019-2
Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom 10.1371/journal.pone.0099489
New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo ? 10.1111/bjh.14264
Haem augments and iron chelation decreases toll-like receptor 4 mediated inflammation in monocytes from sickle cell patients 10.1111/bjh.14663
Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease 10.1111/bjh.14918
Sickle cell vasculopathy: vascular phenotype on fire! 10.1113/JP276705
A Cross-sectional Feasibility Study Testing the Use of Abstract Animations for the Communication and Assessment of Pain (Preprint) 10.2196/preprints.10056
Sickle related events following cardiac catheterisation: risk implication for other invasive procedures 10.1111/bjh.15618
Anakinra, What Is Thy Bidding in Pulmonary Hypertension? 10.1164/rccm.201811-2192ED
Sickle cells and sickle trait in thrombosis 10.1182/blood.2019000694
Cardiac expression of HMOX1 and PGF in sickle cell mice and haem‐treated wild type mice dominates organ expression profiles via Nrf2 ( Nfe2l2 ) 10.1111/bjh.16129
Validation of a composite vascular high‐risk profile for adult patients with sickle cell disease 10.1002/ajh.25624
Abstract Animations for the Communication and Assessment of Pain in Adults: Cross-Sectional Feasibility Study 10.2196/10056
Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study 10.1002/ajh.25799
Imaging Flow Cytometry and Microfluidic Flow Assays Demonstrate Heterocellular Aggregation Of Immature Sickle Erythrocytes To Neutrophils Via Mac-1/VLA-4 Interactions 10.1182/BLOOD.V122.21.318.318
Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia 10.3324/HAEMATOL.2014.108555
Liver injury is associated with mortality in sickle cell disease 10.1111/APT.13347
Arginine metabolism, pulmonary hypertension, and sickle cell disease - In reply 10.1001/JAMA.294.19.2433-B
Clinical and Genetic Variability of Red Blood Cell Hemolysis in Sickle Cell Anemia 10.1182/BLOOD.V118.21.1077.1077
Genetic Determinants of Hemolysis in Sickle Cell Anemia 10.1182/BLOOD.V120.21.2104.2104
Predictors of Mortality in Children and Adolescents with Sickle Cell Disease: The PUSH Study 10.1182/BLOOD.V118.21.515.515
Amerindian/Asian Ancestry and Mortality Are Associated with Allo-Immunization in Adults with Sickle Cell Disease in a Genome Wide Racial Admixture Study 10.1182/BLOOD.V128.22.3650.3650
A Phase 1, Dose-Escalation Study of Topical Sodium Nitrite in Patients with Sickle Cell Anemia and Leg Ulcers 10.1182/BLOOD.V120.21.86.86
End-Alveolar Carbon Monoxide As a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease 10.1182/BLOOD.V124.21.2696.2696
Effect of Aes-103 Anti-Sickling Agent On Oxygen Affinity and Stability of Red Blood Cells From Patients with Sickle Cell Anemia 10.1182/BLOOD.V120.21.85.85
The Oxidant Response Transcription Factor NRF2 Mediates Heme Activation of Placenta Growth Factor Expression in Erythroid Cells, a Contributor to Pulmonary Hypertension in Sickle Cell Disease 10.1182/BLOOD.V126.23.403.403
Thrombospondin-1 Polymorphisms Are Associated with Chronic Kidney Disease in Sickle Cell Anemia 10.1182/BLOOD.V128.22.2491.2491
Laser Speckle Contrast Imaging Characterizes Delayed Reperfusion After Transient Brachial Artery Occlusion in Patients with Sickle Cell Diseas 10.1182/BLOOD.V120.21.1080.1080
Neutrophil-Platelet Aggregation Enables Vaso-Occlusion in Sickle Cell Disease 10.1182/BLOOD.V128.22.1295.1295
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease 10.1182/BLOOD.V106.11.206.206
Amplified expression profiling of platelet transcriptome reveals global activation of arginine metabolic pathways in patients with sickle cell disease 10.1182/BLOOD.V108.11.1536.1536
Placental Growth Factor Is Elevated in Patients with Sickle Cell Disease and Associated with Pulmonary Hypertension, Hemolysis, Inflammation, Iron Overload, and Hepatic Dysfunction 10.1182/BLOOD.V114.22.1531.1531
Hemodynamic Parameters Predict Mortality In Sickle Cell Disease-Related Pulmonary Hypertension 10.1182/BLOOD.V116.21.2668.2668
NT-Pro Brain Natriuretic Peptide Levels and the Risk of Stroke and Death in the Cooperative Study of Sickle Cell Disease 10.1182/BLOOD.V114.22.1541.1541
Blood Flow Is Increased in Wounds and Peri-Wound Area by Laser Speckle Contrast Imaging and Infrared Thermography in Adults with Sickle Cell Leg Ulcers 10.1182/BLOOD.V120.21.1009.1009
Turnover of Heme-Bound Iron Is Associated with Activation of TLR4 and Chemokine Receptor Pathways in the Peripheral Blood Mononuclear Cell Transcriptome in Sickle Cell Anemia 10.1182/BLOOD.V120.21.819.819
Iron Containing Compound Stimulates Expression of Pulmonary Hypertension Promoting Factor PlGF 10.1182/BLOOD.V118.21.900.900
A Cell-Based Adhesion Molecule Bioassay Detects Unexpected Properties of Plasma From Patients with Sickle Cell Disease with Documented Pulmonary Hypertension 10.1182/BLOOD.V118.21.2120.2120
Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease 10.1182/BLOOD.V122.21.2236.2236
The Anti-Sickling Agent Aes-103 Decreases Sickle Erythrocyte Fragility, Hypoxia-Induced Sickling and Hemolysis In Vitro 10.1182/BLOOD.V122.21.940.940
Serum Transferrin: An Independent Predictor of Mortality in Sickle Cell Anemia 10.1182/BLOOD.V118.21.2126.2126
Cardiopulmonary Functional Status in Children with SCD at Baseline: Pulse Pressure As a Biomarker of Early Compromise 10.1182/BLOOD.V124.21.2663.2663
Evaluation of Exercise Capacity In Children with SCD by Six Minute Walk Test 10.1182/BLOOD.V116.21.2664.2664
Increased Transpulmonary Gradient Predicts Functional Class, Mortality, and RV Dysfunction by MRI in Patients with Sickle Cell Associated Pulmonary Hypertension 10.1182/BLOOD.V120.21.89.89
[Correction] Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission (vol 85, pg 24, 2010) 10.1002/AJH.21708
NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study 10.1182/BLOOD.V116.21.1639.1639
Chronic Pain Is An Independent Predictor of Lower 6 Minute Walk Distance In Patients with Sickle Cell Disease: Results From Walk-PHaSST Study 10.1182/BLOOD.V116.21.2658.2658
Predictors of Six-Minute Walk Distance In Adults with Sickle Cell Anemia In the Walk-PHaSST Study 10.1182/BLOOD.V116.21.947.947
Non-Cardiopulmonary Factors Affecting the Six-Minute Walk Distance in Patients with Sickle Cell Disease: Results From the Walk-PHaSST Study 10.1182/BLOOD.V118.21.1074.1074
Stimulation of Nitric Oxide Synthase Activity By Plasma Apolipoproteins: a Biomarker of Endothelial Function in Adults with Sickle Cell Disease 10.1182/BLOOD.V124.21.4015.4015
Pulmonary hypertension in adults and children with sickle cell disease in Nigeria: Prevalence, clinical characteristics and role of endemic tropical infections 10.1182/BLOOD.V110.11.80.80
Prospective evaluation of the prevalence of elevated tricuspid regurgitant jet velocity and associated clinical and echocardiographic factors in children and adolescents with sickle cell disease 10.1182/BLOOD.V110.11.3388.3388
Association of Hemolysis with Clinical Manifestations of Sickle Cell Disease 10.1182/BLOOD.V112.11.2482.2482
Lower Ferritin Concentrations Are Associated with Decreased Hemolysis in Sickle Cell Disease Children without Iron Overload 10.1037/H0092264
Longitudinal Change in Pulmonary Function in Children with Sickle Cell Disease and Associated Factors 10.1164/AJRCCM-CONFERENCE.2010.181.1_MEETINGABSTRACTS.A6732
Plasma Level of NT-Pro-BNP In Children with Sickle Cell Disease Is Associated with Degree of Anemia and Left Ventricular Measures: The PUSH Study 10.1182/BLOOD.V116.21.948.948
Integration of Genomic and Genetic Approaches Highlight a Novel Validated Gene Signature for Pulmonary Hypertension Associated with Sickle Cell Disease 10.1182/BLOOD.V118.21.511.511
Evaluation Of Sildenafil Therapy For Patients With Sickle Cell Disease And Increased Tricuspid Regurgitant Velocity: Preliminary Results Of The Walk-PHaSST Trial 10.1164/AJRCCM-CONFERENCE.2010.181.1_MEETINGABSTRACTS.A2514
Iron, Expression of the Pattern Recognition Receptor-Inflammasome System, and Early Death in Adults with Sickle Cell Disease 10.1182/BLOOD.V124.21.2702.2702
Association of FOXO3A Polymorphisms with Hematocrit, LDH and Longevity in Patients with Sickle Cell Anemia from CSSCD, Walk-Phasst, and PUSH Clinical Trials 10.1182/BLOOD.V126.23.2176.2176
Detection of the mRNA transcription level of several genes of the HIF and NO metabolic pathways in PBMCs of sickle cell disease patients using quantitative RT-PCR assay 10.1182/BLOOD.V110.11.844.844
Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease 10.1161/CIRCRESAHA.116.304577
Response to: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy - Reply 10.1097/00002030-199906180-00028
Abnormal Methacholine Challenge Associated With Pulmonary Arterial Hypertension In Adults With Sickle Cell Disease 10.1164/AJRCCM-CONFERENCE.2011.183.1_MEETINGABSTRACTS.A2013
Genetic Polymorphisms in NEDD4L Are Associated with Pulmonary Hypertension of Sickle Cell Anemia 10.1182/BLOOD.V114.22.2562.2562
Risk Factors for Echocardiography-Determined Cardiopulmonary Abnormalities In Sickle Cell Anemia In the Walk-PHaSST Study 10.1182/BLOOD.V116.21.260.260
The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease 10.1016/B978-0-12-804273-1.00026-0
Imaging flow cytometry documents incomplete resistance of human sickle F-cells to ex vivo hypoxia-induced sickling 10.1182/BLOOD-2014-03-559054
Intravascular hemolysis and the pathophysiology of sickle cell disease 10.1172/JCI89741
Sickle cell disease 10.1038/NRDP.2018.10
Study Of Clinical Characteristics Of Sickle Cell Disease Patients Developing Cor-Pulmonale During Acute Hospitalization 10.1164/AJRCCM-CONFERENCE.2011.183.1_MEETINGABSTRACTS.A5945
Corrigendum 10.1111/BJH.12783
The Impact of Cognitive Function on Adherence to Hydroxyurea Therapy in Patients with Sickle Cell Disease 10.1182/BLOOD.V128.22.2493.2493
An Elevated Tricuspid Regurgitant Jet Velocity In Sickle Cell Disease Is Associated With Polymorphisms In Genes Impacting Innate Immunity 10.1164/AJRCCM-CONFERENCE.2012.185.1_MEETINGABSTRACTS.A6519
Prostacyclin-analog therapy in sickle cell pulmonary hypertension 10.3324/HAEMATOL.2015.131227
Microvascular oxygen consumption during sickle cell pain crisis 10.1182/BLOOD-2013-11-533406
Quantification of Anti-Sickling Effect of Aes-103 in Sickle Cell Disease Using an in Vitro Microfluidic Assay 10.1182/BLOOD.V124.21.2699.2699
Pulmonary Function In Adults With Sickle Cell Related Pulmonary Hypertension 10.1164/AJRCCM-CONFERENCE.2011.183.1_MEETINGABSTRACTS.A1932
Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia 10.1002/AJH.24635
Platelet Nucleation on Arrested Neutrophils Drives Vaso-Occlusion in Sickle Cell Disease 10.1182/BLOOD.V126.23.414.414
Health Care Utilization for Painful Events Is Associated with Early Mortality in a Contemporary Population of Adults with Sickle Cell Anemia 10.1182/BLOOD.V118.21.2115.2115
Imaging Flow Cytometry Documents Incomplete Resistance Of F-Cells To Hypoxia-Induced Sickling In Blood Samples From Patients With Sickle Cell Anemia 10.1182/BLOOD.V122.21.183.183
Plasma Thrombospondin 1 Is Increased and Associated with Markers of Vasculopathy In Sickle Cell Disease 10.1182/BLOOD.V116.21.946.946
Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease 10.1073/PNAS.1610435113
Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease 10.3324/HAEMATOL.2015.125229
Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kruppel-like factor 10.1182/BLOOD-2013-11-539718
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli 10.1172/JCI.INSIGHT.89761
Placenta Growth Factor Is Regulated By Heme-Bound Iron Via Erythroid Kruppel-Like Factor In Erythroid Cells and Is Linked To Iron Status In Vivo In Sickle Cell Disease and Hereditary Hemochromatosis 10.1182/BLOOD.V122.21.432.432
Vascular complications after splenectomy for hematologic disorders 10.1182/BLOOD-2009-10-251439
Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I 10.1182/ASHEDUCATION-2008.1.186
Pulmonary Complications of Sickle Cell Disease 10.1164/RCCM.201111-2082CI
Childhood Hodgkin and Non-Hodgkin Lymphomas 10.1542/PIR.12-6-171
Sickle particulars of microparticles 10.1182/blood.2020006303
Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts 10.1371/journal.pone.0237543
Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice 10.3389/FIMMU.2020.01910
Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity 10.1016/J.EXPHEM.2020.02.005
Platelet Extracellular Vesicles Drive Inflammasome-IL-1 beta-Dependent Lung Injury in Sickle Cell Disease 10.1164/RCCM.201807-1370OC
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings 10.1182/BLOODADVANCES.2019000883
Free heme regulates placenta growth factor through NRF2-antioxidant response signaling 10.1016/J.FREERADBIOMED.2019.08.009
Identifying Clinical and Research Priorities in Sickle Cell Lung Disease An Official American Thoracic Society Workshop Report 10.1513/ANNALSATS.201906-433ST
Health-related quality of life in sickle cell disease REPLY 10.1038/S41572-019-0080-5
Clinical and Laboratory Predictors of 30-Day Hospital Readmission Risk in Adult Patients with Sickle Cell Disease 10.1182/BLOOD-2018-99-115248
Sleep phenotype in the Townes mouse model of sickle cell disease 10.1007/S11325-018-1711-X
Heterogeneity in Multi-Organ Expression of HO-1 and P1GF in Sickle Mice Mimic Exposure of Non-Sickle Mice to Extracellular Heme Via Nrf2-Dependent Pathways 10.1182/BLOOD-2018-99-113451
Clinical Outcomes Associated With Sickle Cell Trait A Systematic Review 10.7326/M18-1161
Exercise training: a prescription for sickle-cell disease? 10.1016/S2352-3026(18)30178-9
Assessment of Iron Overload Impact on QTc Interval in Patients with Sickle Cell Disease 10.1182/BLOOD-2018-99-115125
Brief topical sodium nitrite and its impact on the quality of life in patients with sickle leg ulcers 10.1097/MD.0000000000012614
Simultaneous polymerization and adhesion under hypoxia in sickle cell disease 10.1073/PNAS.1807405115
Cellular Biophysical Markers of Hydroxyurea Treatment in Sickle Cell Disease 10.1117/12.2273139
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease 10.1182/BLOOD.V128.22.2474.2474
Thrombospondin-1 Gene Polymorphism Is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia 10.1182/BLOOD.V126.23.970.970
Elevated Pulse Pressure Is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease 10.1182/BLOOD.V124.21.2711.2711
Serum B12 Levels In Children with Sickle Cell Disease Are Lower Than In Healthy Control Subjects 10.1182/BLOOD.V116.21.1647.1647
Human genetic diseases of proteolysis 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.3.CO;2-B
Identifying adolescent and young adult patients with sickle cell disease at highest risk of death 10.1002/ajh.26035
Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease 10.1002/HEP.31239
Kynurenine-derived Electrophiles: Potential Adaptive Mediators in Sickle Cell Disease 10.1016/J.FREERADBIOMED.2020.10.103
TheCYB5R3 (c)(.350C>G)andG6PDA alleles modify severity of anemia in malaria and sickle cell disease 10.1002/AJH.25941
A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN) 10.1182/BLOOD-2019-125790
Sickle Cell Disease Promotes Dysregulation of Hepatic Iron Homeostasis By Regulating Hepcidin Expression 10.1182/BLOOD-2019-131921
Nrf2 Null Mice Are Deficient in CD169(+) Macrophages, Associated with Impaired Erythroid Response and Delayed Recovery from Acute Blood Loss 10.1182/BLOOD-2019-127295
A Phase II Trial of Topical Sodium Nitrite in Patients with Sickle Cell Disease and Leg Ulcers 10.1182/BLOOD-2019-124440
Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease 10.1182/BLOOD-2019-124048
Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice 10.1182/BLOOD-2019-127224
Impaired Bile Secretion Promotes Chronic Liver Injury in Sickle Cell Disease 10.1182/BLOOD-2019-131915
360 degrees View of a Day Hospital Program Performing Exchange Transfusion and Outpatient Pain Management on Adults with Sickle Cell Disease 10.1182/BLOOD-2019-122397
Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease 10.1002/ajh.26243
Gene therapy as the new frontier for Sickle Cell Disease. 10.2174/0929867328666210527092456
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. 10.1001/jama.2021.3414
The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease. 10.3389/fimmu.2020.561917